• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation.

作者信息

Pignone Michael, Alberts Mark J, Colwell John A, Cushman Mary, Inzucchi Silvio E, Mukherjee Debabrata, Rosenson Robert S, Williams Craig D, Wilson Peter W, Kirkman M Sue

机构信息

Department of Medicine, University of North Carolina, Chapel Hill, North Carolina, USA.

出版信息

Diabetes Care. 2010 Jun;33(6):1395-402. doi: 10.2337/dc10-0555.

DOI:10.2337/dc10-0555
PMID:20508233
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2875463/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f01e/2875463/bf462f934279/zdc0061083120001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f01e/2875463/bf462f934279/zdc0061083120001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f01e/2875463/bf462f934279/zdc0061083120001.jpg

相似文献

1
Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation.阿司匹林用于糖尿病患者心血管事件的一级预防：美国糖尿病协会立场声明、美国心脏协会科学声明及美国心脏病学基金会专家共识文件
Diabetes Care. 2010 Jun;33(6):1395-402. doi: 10.2337/dc10-0555.
2
Review of an article: aspirin for primary prevention of cardiovascular events in people with diabetes. A position statement of the American Diabetes Association (ADA), a scientific statement of the American Heart Association(AHA), and an expert consensus document of the American College of Cardiology Foundation (ACCF). Diabetes Care, 33:6; June 2010; 1395-1402.一篇文章的综述：阿司匹林用于糖尿病患者心血管事件的一级预防。美国糖尿病协会（ADA）的立场声明、美国心脏协会（AHA）的科学声明以及美国心脏病学基金会（ACCF）的专家共识文件。《糖尿病护理》，第33卷，第6期；2010年6月；第1395 - 1402页。
J Vasc Nurs. 2010 Dec;28(4):154-5. doi: 10.1016/j.jvn.2010.10.002.
3
Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation.阿司匹林用于糖尿病患者心血管事件的一级预防：美国糖尿病协会立场声明、美国心脏协会科学声明及美国心脏病学基金会专家共识文件
Circulation. 2010 Jun 22;121(24):2694-701. doi: 10.1161/CIR.0b013e3181e3b133. Epub 2010 May 27.
4
Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association.糖尿病患者心血管疾病的一级预防：美国心脏协会和美国糖尿病协会的科学声明
Circulation. 2007 Jan 2;115(1):114-26. doi: 10.1161/CIRCULATIONAHA.106.179294. Epub 2006 Dec 27.
5
[Acetylsalicylic acid and diabetes mellitus].[乙酰水杨酸与糖尿病]
Acta Med Port. 2002 May-Jun;15(3):199-202.
6
Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus.阿司匹林用于糖尿病患者一级预防的效果。
N Engl J Med. 2018 Oct 18;379(16):1529-1539. doi: 10.1056/NEJMoa1804988. Epub 2018 Aug 26.
7
[Aspirin use in patients with diabetes mellitus].糖尿病患者使用阿司匹林的情况
Med Clin (Barc). 2004 Jul 10;123(6):237; author reply 239. doi: 10.1016/s0025-7753(04)74472-3.
8
[Should we treat all diabetic patients with aspirin in primary prevention?].[在一级预防中，我们应该对所有糖尿病患者使用阿司匹林进行治疗吗？]
Rev Med Suisse. 2005 Jun 1;1(22):1500-4.
9
[Aspirin use in patients with diabetes mellitus].[糖尿病患者使用阿司匹林的情况]
Med Clin (Barc). 2004 Jul 10;123(6):238-9; author reply 239. doi: 10.1016/s0025-7753(04)74474-7.
10
[Aspirin use in patients with diabetes mellitus].[糖尿病患者使用阿司匹林的情况]
Med Clin (Barc). 2004 Jul 10;123(6):237-8; author reply 239. doi: 10.1016/s0025-7753(04)74473-5.

引用本文的文献

1
Diabetes mellitus associated neurovascular lesions in the retina and brain: A review.糖尿病相关的视网膜和脑部神经血管病变：综述
Front Ophthalmol (Lausanne). 2022 Oct 31;2:1012804. doi: 10.3389/fopht.2022.1012804. eCollection 2022.
2
The Role of Cilostazol, a Phosphodiesterase-3 Inhibitor, in the Development of Atherosclerosis and Vascular Biology: A Review with Meta-Analysis.西洛他唑，一种磷酸二酯酶-3 抑制剂，在动脉粥样硬化和血管生物学发展中的作用：综述与荟萃分析。
Int J Mol Sci. 2024 Feb 23;25(5):2593. doi: 10.3390/ijms25052593.
3
Diabetic Vasculopathy: Molecular Mechanisms and Clinical Insights.

本文引用的文献

1
Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials.阿司匹林用于糖尿病患者心血管事件的一级预防：随机对照试验的荟萃分析
BMJ. 2009 Nov 6;339:b4531. doi: 10.1136/bmj.b4531.
2
Aspirin for primary prevention of cardiovascular events in patients with diabetes: A meta-analysis.阿司匹林用于糖尿病患者心血管事件一级预防的荟萃分析。
Diabetes Res Clin Pract. 2010 Feb;87(2):211-8. doi: 10.1016/j.diabres.2009.09.029. Epub 2009 Oct 23.
3
Aspirin for the primary prevention of cardiovascular events: a systematic review and meta-analysis comparing patients with and without diabetes.
糖尿病血管病变：分子机制与临床新见
Int J Mol Sci. 2024 Jan 9;25(2):804. doi: 10.3390/ijms25020804.
4
Cardiovascular Protection of Aspirin in Chronic Kidney Disease Patients: An Updated Systematic Review and Meta-Analysis.阿司匹林在慢性肾脏病患者中的心血管保护作用：一项更新的系统评价和荟萃分析。
Curr Vasc Pharmacol. 2024;22(4):287-296. doi: 10.2174/1570161121666230530154647.
5
Aspirin Use among Saudi Adults: The Prevalence and Users' Characteristics.沙特成年人阿司匹林的使用情况：患病率及使用者特征
Saudi Pharm J. 2022 Apr;30(4):340-346. doi: 10.1016/j.jsps.2022.02.003. Epub 2022 Feb 11.
6
Why Is COVID-19 More Severe in Patients With Diabetes? The Role of Angiotensin-Converting Enzyme 2, Endothelial Dysfunction and the Immunoinflammatory System.为什么2型糖尿病患者感染新冠病毒后病情更严重？血管紧张素转换酶2、内皮功能障碍和免疫炎症系统的作用。
Front Cardiovasc Med. 2021 Feb 3;7:629933. doi: 10.3389/fcvm.2020.629933. eCollection 2020.
7
Impact of acetylsalicylic acid in patients undergoing cerebral aneurysm surgery - should the neurosurgeon really worry about it?阿司匹林对脑动脉瘤手术患者的影响——神经外科医生真的需要为此担心吗？
Neurosurg Rev. 2021 Oct;44(5):2889-2898. doi: 10.1007/s10143-021-01476-7. Epub 2021 Jan 25.
8
Guidelines on multidisciplinary approaches for the prevention and management of diabetic foot disease (2020 edition).糖尿病足病预防与管理的多学科方法指南（2020年版）
Burns Trauma. 2020 Jul 6;8:tkaa017. doi: 10.1093/burnst/tkaa017. eCollection 2020.
9
Medical Reversals in Family Practice: A Review.家庭医疗中的医疗逆转：一项综述
Curr Ther Res Clin Exp. 2020 Feb 22;92:100579. doi: 10.1016/j.curtheres.2020.100579. eCollection 2020.
10
Aspirin, clopidogrel and prasugrel monotherapy in patients with type 2 diabetes mellitus: a double-blind randomised controlled trial of the effects on thrombotic markers and microRNA levels.阿司匹林、氯吡格雷和普拉格雷单药治疗 2 型糖尿病患者：对血栓形成标志物和 microRNA 水平影响的双盲随机对照试验。
Cardiovasc Diabetol. 2020 Jan 7;19(1):3. doi: 10.1186/s12933-019-0981-3.
阿司匹林用于心血管事件的一级预防：比较伴或不伴糖尿病患者的系统评价和荟萃分析。
Diabetes Care. 2009 Dec;32(12):2300-6. doi: 10.2337/dc09-1297. Epub 2009 Sep 9.
4
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.阿司匹林用于血管疾病的一级和二级预防：来自随机试验的个体参与者数据的协作荟萃分析
Lancet. 2009 May 30;373(9678):1849-60. doi: 10.1016/S0140-6736(09)60503-1.
5
Aspirin for the primary prevention of cardiovascular events: an update of the evidence for the U.S. Preventive Services Task Force.阿司匹林用于心血管事件的一级预防：美国预防服务工作组证据更新
Ann Intern Med. 2009 Mar 17;150(6):405-10. doi: 10.7326/0003-4819-150-6-200903170-00009.
6
Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement.阿司匹林用于预防心血管疾病：美国预防服务工作组建议声明
Ann Intern Med. 2009 Mar 17;150(6):396-404. doi: 10.7326/0003-4819-150-6-200903170-00008.
7
Aspirin resistance transient laboratory finding or important clinical entity?阿司匹林抵抗：短暂的实验室检查结果还是重要的临床现象？
J Am Coll Cardiol. 2009 Feb 24;53(8):678-80. doi: 10.1016/j.jacc.2008.11.018.
8
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance".低剂量阿司匹林对血小板环氧化酶的抑制作用在血小板功能检测中并未始终得到体现：对阿司匹林“抵抗”的启示。
J Am Coll Cardiol. 2009 Feb 24;53(8):667-77. doi: 10.1016/j.jacc.2008.10.047.
9
Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial.低剂量阿司匹林用于2型糖尿病患者动脉粥样硬化事件的一级预防：一项随机对照试验。
JAMA. 2008 Nov 12;300(18):2134-41. doi: 10.1001/jama.2008.623. Epub 2008 Nov 9.
10
The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease.预防动脉疾病和糖尿病进展（POPADAD）试验：糖尿病和无症状外周动脉疾病患者中阿司匹林和抗氧化剂的析因随机安慰剂对照试验。
BMJ. 2008 Oct 16;337:a1840. doi: 10.1136/bmj.a1840.